Menu

Month: May 2024

Ohio Community Health Center CEOs, Lawmakers Urge Passage of State Contract Pharmacy Protection Bill

Shannon Young, Associate Editor/Senior Writer Views
The Statehouse in Columbus, Ohio.
Ohio federally qualified health center (FQHC) leaders called on state lawmakers Tuesday to pass newly introduced legislation that would end 340B contract pharmacy restrictions.
Ohio federally qualified health center (FQHC) leaders called on state lawmakers Tuesday to pass newly introduced legislation that would end [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Congressional Researchers Provide Contract Pharmacy Report on 340B as Legislators Mull Bills

Rich Daly, Editor in Chief Views
Congressional Research Service wordmark and logo
The Congressional Research Service issued a summary of the range of policy actions affecting 340B contract pharmacy use in recent years
Congress’ in-house non-partisan research arm recently produced a summary of the range of policy actions affecting 340B contract pharmacy use [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Bayer Adds Prostate Cancer Drug to Contract Pharmacy Restrictions

Rich Daly, Editor in Chief Views
Bayer wordmark on building
Bayer added a previously excluded drug to its list of products that face contract pharmacy restrictions.
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

No Adverse Findings in First HRSA Drugmaker Audit of 2024

Rich Daly, Editor in Chief Views
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer.
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

News Alert

ASAP 340B-Backed Bill Introduced in House

Shannon Young, Associate Editor/Senior Writer Views
Capitol building
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Appeals Court Contract Pharmacy Restrictions Decision Leaves Unanswered Questions, Ups Pressure for Legislative Action

William Newton, Associate Editor/Senior Writer Views
The D.C. Circuit decided that two drugmakers' current contract pharmacy restrictions were legal, but it left open the possibility that more onerous restrictions may not be.
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

CMS Drops ‘Stacking’ Proposal Which Could Have Boosted 340B Savings

Rich Daly, Editor in Chief Views
CMS said it was no longer considering a "stacking" proposal for Medicaid drug pricing calculations, which could have increased 340B savings.
Federal regulators said they were dropping from consideration a proposal for “stacking” discounts as part of an update to Medicaid [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Industry Insights Logo

Guidance on 340B ESP Use and Management

Sponsored Content Views
Quality Assurance Tips to Maximize Your Contract Pharmacy Savings

SPONSORED CONTENT

Since 2020, select drug manufacturers have begun deploying restrictions or limitations on the sale of their products through the 340B program. This has proven to be a marketplace disruptor that has shifted the landscape of the 340B contract pharmacy program, as covered

…
Read More »

340B Hospitals Prescribe Part D Drugs to a Much Higher Share of Vulnerable Populations, Says Hospital-Backed Report

Shannon Young, Associate Editor/Senior Writer Views
A hospital-funded study found 340B hospitals prescribe a higher share of Medicare Part D drugs to a higher share of vulnerable patients.
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Teva Adds 40th Drug to Contract Pharmacy Restriction Policy

Rich Daly, Editor in Chief Views
Teva added a biosimilar of AbbVie's blockbuster Humira to its list of products included in its 340B contract pharmacy restrictions.
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live